REGENERON PHARMACEUTICALS - COM - Call

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COM
Number of holders
0
Total 13F shares, excl. options
0
Shares change
-1.1K
Total reported value, excl. options
$0
Value change
-$338K
Number of sells
-1
Price
$375.51

Significant Holders of REGENERON PHARMACEUTICALS - COM - Call as of Q4 2019

10 filings reported holding 75886F907 - REGENERON PHARMACEUTICALS - COM - Call as of Q4 2019.
REGENERON PHARMACEUTICALS - COM - Call has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 0 shares .
Largest 10 shareholders include WINTRUST INVESTMENTS LLC (0 shares), SG Americas Securities, LLC (41.2K shares), IMC-Chicago, LLC (34.8K shares), JPMORGAN CHASE & CO (22.6K shares), Allianz Asset Management GmbH (6.5K shares), HBK INVESTMENTS L P (1.5K shares), SIMPLEX TRADING, LLC (762 shares), CLEAR STREET MARKETS LLC (531 shares), FLAGSHIP HARBOR ADVISORS, LLC (4 shares), and TWO SIGMA SECURITIES, LLC (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.